Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/9/06 → 08/8/09 |
Funding
- MedImmune Incorporated: $11,192.00
A Phase I Randomized, Double-Blind Trial of the Safety and Immunogenicity of FluMist a Live, Intranasal Influenza Virus Vaccine vs. Placebo in Immunocompromised Children Ages 5 Through 17 Years of Age
- Nachman, Sharon (PI)
Project: Research